9258 Wealth Management, LLC Catalyst Pharmaceuticals, Inc. Call Options Transaction History
9258 Wealth Management, LLC
- $664 Million
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CPRX
# of Institutions
390Shares Held
99.9MCall Options Held
37KPut Options Held
20.5K-
Black Rock Inc. New York, NY18.7MShares$414 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.5MShares$188 Million0.0% of portfolio
-
State Street Corp Boston, MA5.53MShares$122 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.42MShares$75.7 Million2.1% of portfolio
-
Goldman Sachs Group Inc New York, NY3.14MShares$69.4 Million0.01% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.27B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...